EUVIMEDEUVIMED entdecken
Crossref

SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence

Jacek Kubica, Aldona Kubica

Clinical Diabetology · 28.04.2026

DOI: 10.5603/cd.112125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Diabetology, online erschienen am 28.04.2026. Verfasst von Jacek Kubica und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kubica, J., & Kubica, A. (2026). SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. https://doi.org/10.5603/cd.112125

Vancouver

Kubica J, Kubica A. SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. 2026. doi:10.5603/cd.112125

BibTeX
@article{Kubica2026,
  author = {Kubica, Jacek and Kubica, Aldona},
  title = {SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence},
  journal = {Clinical Diabetology},
  year = {2026},
  doi = {10.5603/cd.112125}
}
Kostenlos starten →